Skip Ribbon Commands
Skip to main content
Dr Soh Shui Boon

Dr Soh Shui Boon


Senior Consultant

Changi General Hospital

Specialty: Endocrinology

Sub-specialties: Thyroid Diseases

Clinical Appointments

  • Senior Consultant Endocrinology Changi General HospitalChangi General Hospital


Dr Soh graduated from Faculty of Medicine, National University of Singapore in 2002 and became a member of the Royal College of Physicians of the United Kingdom in 2007. She subsequently completed postgraduate specialty training in endocrinology and did a one-year sabbatical in The Alfred Hospital, Melbourne from 2012 to 2013 to pursue her interest in thyroid diseases.

She is currently a Senior Consultant Endocrinologist at Changi General Hospital (CGH). Dr Soh is also a senior clinical lecturer for Yong Loo Lin School of Medicine, and has been associate program director of Singhealth Advanced Internal Medicine Residency Program since the start of the program in 2013.


  • MBBS (Singapore)
  • MRCP (United Kingdom)
  • Specialist Accreditation in Endocrinology (Singapore)
  • Fellowship in Thyroid Diseases (The Alfred Hospital, Melbourne, Australia)

Professional Appointments and Committee Memberships

  • Senior Clinical Lecturer, NUS Yong Loo Lin School of Medicine
  • Associate Program Director, SingHealth Advanced Internal Medicine Residency Program
  • Core Faculty Member, SingHealth Endocrinology Senior Residency Program
  • Physician Faculty Member, SingHealth PGY1 Residency Program
  • Physician Faculty Member and Mentor, SingHealth Internal Medicine Residency Program


  • SingHealth Residency Program Outstanding Faculty Award (2017)
  • Eastern Health Alliance Caring Award – Silver (2017)

Research Interests


  • Classification and Laboratory Diagnosis of Diabetes Mellitus Shui-Boon Soh, Duncan J Topliss, 2014, Endocrinology and Diabetes – a Problem-Oriented Approach, Springer (NY). 2014(1): 347-359
  • Novel Use of Rituximab in a case of Riedel’s Thyroiditis refractory to Glucocorticoids and Tamoxifen Shui-Boon Soh, Alan Pham, Robyn E O’Hehir, Martin Cherk, Duncan J Topliss J Clin Endo Metab. Sept 2013; 98(9): 3543-49
  • Use and Misuse of Thyroid Hormone Duncan J Topliss, Shui-Boon Soh Singapore Medical Journal. Jul 2013; 54(7): 406-10
  • Thyroid dysfunction in pregnancy: optimising obstetric outcomes Shui-Boon Soh, Duncan J Topliss Endocrinology Today. Apr 2013; 2(2): 8-16

Research Trials

  • Effects of 4-month therapy of levothyroxine on non-alcoholic fatty liver disease (NAFLD) and diabetes control in diabetic male patients (Site PI; completed)
  • A 24-week multicentre, randomized, double-blinded, placebo-controlled, parallel-group, phase 3 trial to evaluate the efficacy and safety of Dapagliflozin added to the therapy of Asian subjects with type 2 diabetes who have inadequate glycemic control on insulin (Site Co-I; completed)
  • Prospective diabetes registry of patients with type 2 diabetes mellitus on SGLT2 inhibitor therapy in Singapore (Site Co-I; ongoing) • EDEN study - ELO water in diabetes care for enhancement of blood glucose control (Site Co-I; ongoing)
  • PACES PA study - Prospective study assessing blood pressure, cardiovascular, endothelial and other outcomes post surgical and medical treatment in patients with primary aldosteronism (Co-I; ongoing)